Efficacy of a high-dose proton pump inhibitor in patients with gastroesophageal reflux disease: a single center, randomized, open-label trial

BACKGROUND: The extraesophageal manifestations of gastroesophageal reflux disease (GERD) are more difficult to manage than the typical symptoms. The efficacy of high-dose and standard-dose proton pump inhibitors against these atypical symptoms is not yet established. METHODS: In this single center,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Jae Ho, Shin, Cheol Min, Yoon, Hyuk, Park, Young Soo, Kim, Nayoung, Lee, Dong Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433117/
https://www.ncbi.nlm.nih.gov/pubmed/32811427
http://dx.doi.org/10.1186/s12876-020-01410-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433117/
https://www.ncbi.nlm.nih.gov/pubmed/32811427
http://dx.doi.org/10.1186/s12876-020-01410-z

Ejemplares similares